Back to Search
Start Over
The Role of Human Papillomavirus Genotyping in Cervical Cancer Screening: A Large-Scale Evaluation of the cobas HPV Test
- Source :
- Cancer Epidemiology, Biomarkers & Prevention. 24:1304-1310
- Publication Year :
- 2015
- Publisher :
- American Association for Cancer Research (AACR), 2015.
-
Abstract
- Background: The cobas HPV Test (“cobas”; Roche Molecular Systems) detects HPV16 and HPV18 individually, and a pool of 12 other high-risk (HR) HPV types. The test is approved for (i) atypical squamous cells of undetermined significance (ASC-US) triage to determine need for colposcopy, (ii) combined screening with cytology (“cotesting”), and (iii) primary HPV screening. Methods: To assess the possible value of HPV16/18 typing, >17,000 specimens from a longitudinal cohort study of initially HPV-positive women (HC2, Qiagen) were retested with cobas. To study accuracy, cobas genotyping results were compared with those of an established method, the Linear Array HPV Genotyping Test (LA, Roche Molecular Systems). Clinical value of the typing strategy was evaluated by linking the cobas results (supplemented by other available typing results) to 3-year cumulative risks of CIN3+. Results: Grouped hierarchically (HPV16, else HPV18, else other HR types, else negative), the κ statistic for agreement between cobas and LA was 0.86 [95% confidence interval (CI), 0.86–0.87]. In all three scenarios, HPV16-positive women were at much higher 3-year risk of CIN3+ than HPV16-negative women: women ages 21 and older with ASC-US (14.5%; 95% CI, 13.5%–15.5% vs. 3.5%; 95% CI, 3.3–3.6); women ages 30 years and older that were HPV-positive cytology-negative (10.3%; 95% CI, 9.6–11.1 vs. 2.3%; 95% CI, 2.2–2.4); and all women 25 years and older that were HPV-positive (18.5%; 95% CI, 17.8–19.2 vs. 4.3%; 95% CI, 4.2–4.4). Conclusion: The cobas and LA results show excellent agreement. The data support HPV16 typing. Impact: HPV16 typing is useful in the management of HPV-positive/cytology-negative women in cotesting, of all HPV-positive women in primary HPV testing, and perhaps in the management of HPV-positive women with ASC-US. Cancer Epidemiol Biomarkers Prev; 24(9); 1304–10. ©2015 AACR. See related commentary by Del Mistro, p. 1302
- Subjects :
- Adult
medicine.medical_specialty
Genotyping Techniques
Epidemiology
Uterine Cervical Neoplasms
Cervical intraepithelial neoplasia
Cohort Studies
Young Adult
Risk Factors
Atypical Squamous Cells of the Cervix
medicine
Humans
Cervix
Genotyping
Early Detection of Cancer
Aged
Aged, 80 and over
Colposcopy
Gynecology
Cervical cancer
Human papillomavirus 16
Human papillomavirus 18
medicine.diagnostic_test
business.industry
Middle Aged
Uterine Cervical Dysplasia
medicine.disease
female genital diseases and pregnancy complications
Confidence interval
medicine.anatomical_structure
Oncology
Linear Array HPV Genotyping Test
Female
business
Cohort study
Subjects
Details
- ISSN :
- 15387755 and 10559965
- Volume :
- 24
- Database :
- OpenAIRE
- Journal :
- Cancer Epidemiology, Biomarkers & Prevention
- Accession number :
- edsair.doi.dedup.....03713a97e878b259936da8bd9decfa26
- Full Text :
- https://doi.org/10.1158/1055-9965.epi-14-1353